Back
BeiGene Vs. Theravance Biopharma Industry Stock Comparison
Sell
38
BGNE
BeiGene
Last Price:
156.61
Seasonality Move:
18.09%
Sell
47
TBPH
Theravance Biopharma
Last Price:
8.99
Seasonality Move:
-13.46%
Sell
38
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $153.58. The Score for BGNE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.12. The Score for TBPH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing slight selling pressure.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.58 | Sell |
| Relative Strength Index (14 RSI): | 57.06 | Buy |
| Chaikin Money Flow: | 109352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.45 - 155.13) | Buy |
| Bollinger Bands (100): | (146.66 - 175.92) | Sell |
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.4 | Sell |
| Chaikin Money Flow: | -112928 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.96 - 9.52) | Sell |
| Bollinger Bands (100): | (8.71 - 10.51) | Sell |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.71 | Buy |
| 20-day SMA: | 144.32 | Buy |
| 50-day SMA: | 154.61 | Sell |
| 200-day SMA: | 176.23 | Sell |
| 8-day EMA: | 143.34 | Buy |
| 20-day EMA: | 144.96 | Buy |
| 50-day EMA: | 151.94 | Buy |
| 200-day EMA: | 173.44 | Sell |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.27 | Sell |
| 20-day SMA: | 9.33 | Sell |
| 50-day SMA: | 9.07 | Buy |
| 200-day SMA: | 9.62 | Sell |
| 8-day EMA: | 9.25 | Sell |
| 20-day EMA: | 9.26 | Sell |
| 50-day EMA: | 9.24 | Sell |
| 200-day EMA: | 9.65 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $4.67 per share.
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
BeiGene Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theravance Biopharma Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||